CRMD — CorMedix Inc.
$7.85-3.09%
Last close: · regular session
After-hours $7.75 -1.27% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for CRMD in the TickerWise workspace.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 64
- Website: https://www.cormedix.com
Latest SEC filings for CRMD
Latest CRMD news
- Cormedix gets FDA priority review for Rezzayo label expansion Read article
- CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.